Leerink Partnrs Expects Reduced Earnings for Quanterix

Quanterix Co. (NASDAQ:QTRX) – Investment analysts at Leerink Partnrs lowered their FY2024 earnings per share (EPS) estimates for Quanterix in a note issued to investors on Tuesday, January 7th. Leerink Partnrs analyst P. Souda now expects that the company will post earnings of ($0.94) per share for the year, down from their previous estimate of ($0.88). The consensus estimate for Quanterix’s current full-year earnings is ($0.88) per share. Leerink Partnrs also issued estimates for Quanterix’s Q4 2024 earnings at ($0.24) EPS, Q1 2025 earnings at ($0.26) EPS, Q2 2025 earnings at ($0.24) EPS, Q3 2025 earnings at ($0.18) EPS and FY2025 earnings at ($0.88) EPS.

Separately, TD Cowen boosted their price target on Quanterix from $13.50 to $16.00 and gave the stock a “hold” rating in a research note on Wednesday, November 13th.

Quanterix Stock Down 0.5 %

Shares of NASDAQ QTRX opened at $11.73 on Thursday. The firm has a market cap of $451.89 million, a P/E ratio of -11.17 and a beta of 1.33. Quanterix has a twelve month low of $9.87 and a twelve month high of $29.70. The company has a 50 day moving average of $12.05 and a 200 day moving average of $12.70.

Institutional Trading of Quanterix

A number of hedge funds have recently bought and sold shares of QTRX. JPMorgan Chase & Co. grew its stake in shares of Quanterix by 28.1% during the 3rd quarter. JPMorgan Chase & Co. now owns 217,957 shares of the company’s stock valued at $2,825,000 after purchasing an additional 47,873 shares during the period. Exome Asset Management LLC raised its holdings in Quanterix by 23.2% in the 3rd quarter. Exome Asset Management LLC now owns 73,501 shares of the company’s stock worth $953,000 after purchasing an additional 13,851 shares during the period. Peapack Gladstone Financial Corp purchased a new position in Quanterix during the third quarter valued at $131,000. Empire Financial Management Company LLC increased its position in Quanterix by 100.0% in the third quarter. Empire Financial Management Company LLC now owns 37,500 shares of the company’s stock worth $486,000 after buying an additional 18,750 shares in the last quarter. Finally, Geode Capital Management LLC raised its stake in shares of Quanterix by 2.2% in the third quarter. Geode Capital Management LLC now owns 858,667 shares of the company’s stock worth $11,131,000 after buying an additional 18,231 shares during the period. Hedge funds and other institutional investors own 86.48% of the company’s stock.

Quanterix Company Profile

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.